Arp Americas »

Apellis Pharmaceuticals shares owned by Arp Americas

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Arp Americas from 13F filings

Historical chart of Arp Americas investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Arp Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Arp Americas

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.1M 51k 40.23

More positions owned by Arp Americas

Janus Henderson Group Ord Shs (JHG)
Day One Biopharmaceuticals I (DAWN)
Select Medical Holdings Corporation (SEM)
Norfolk Southern (NSC)
Talkspace (TALK)
Apellis Pharmaceuticals (APLS)
Amicus Therapeutics (FOLD)
Electronic Arts (EA)
Great Lakes Dredge & Dock Corporation
Thermon Group Holdings (THR)
Qorvo (QRVO)
Cabot Oil & Gas Corporation (CTRA)
Stellar Bancorp Ord (STEL)
Penumbra (PEN)
Heritage Commerce (HTBK)

View all positions for Arp Americas

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
venBio Select Advisor
Vanguard Group
Deep Track Capital
Rtw Investments
BlackRock
UBS Group
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
AQR Capital Management

View all funds holding Apellis Pharmaceuticals